Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.7 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |